MEDP Stock Price | Medpace Holdings Inc P/E, Revenue, EPS, & Forecasts

Medpace Holdings Inc • MEDP

MEDP current price

$341.14+9.35%

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs
News

+2.26%

+1.75%

+4.56%

-19.61%

+9.35%

MAX

+1,116.62%

About Medpace Holdings Inc

Ticker

MEDP

Trading on

NASDAQ

ISIN

US58506Q1094

Industry

Diagnostics & Research

Sector

Healthcare

CEO

Dr. August James Troendle M.D.

Headquarters

5375 Medpace Way, Cincinnati, OH, United States, 45227

Employees

5,900

Website

medpace.com

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Metrics

BasicAdvanced

Market cap

$10.7B

P/E ratio

30.03

EPS

$11.41

Dividend Yield

0.00%

Beta

1.37

Forward P/E ratio

26.32

EBIDTA

$438M

Ex dividend date

Price & volume

Market cap

$10.7B

Average daily volume

0.3M

90-day return

4.56%

30-day return

1.75%

7-day return

2.26%

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

30.03

Forward P/E

26.32

PEG ratio

1.63

Trailing P/E

30.03

Price to sales

5.14

Price to book

12.08

Earnings

EPS

$11.41

EPS estimate (current quarter)

$2.78

EPS estimate (next quarter)

$2.86

EBITDA

$438M

Revenues (TTM)

$2.07B

Revenues per share (TTM)

$67.02

Technicals

Beta

1.37

52-week High

$459.77

52-week Low

$277.72

50-day moving average

$339.14

200-day moving average

$374.55

Short ratio

3.04

Short %

5.49%

Management effectiveness

ROE (TTM)

54.08%

ROA (TTM)

14.31%

Profit margin

17.66%

Gross profit margin

$925M

Operating margin

21.05%

Growth

Quarterly earnings growth (YoY)

35.60%

Quarterly revenue growth (YoY)

8.30%

Share stats

Outstanding Shares

31.1M

Float

25.5M

Insiders %

17.83%

Institutions %

86.00%

Analyst Insights & forecasts

37% Buy

54% Hold

9% Sell

Based on information from 11 analysts.

Average price target

$347.92

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

$2.46

$2.22

10.81%

Q4 • 23Beat

$3.20

$2.47

29.55%

Q1 • 24Beat

$2.75

$2.54

8.27%

Q2 • 24Beat

$3.01

$2.78

8.27%

Q3 • 24Beat

Q4 • 24Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$528M

$88.4M

16.73%

Q2 • 24

$533M

$96.4M

18.08%

Q3 • 24

0.99%

9.14%

8.07%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$1.92B

$1.16B

60.23%

Q2 • 24

$2.08B

$1.2B

57.71%

Q3 • 24

8.54%

3.99%

4.19%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$116M

$-12.8M

$0.7M

$104M

Q2 • 24

$149M

$-10.5M

$6.3M

$139M

Q3 • 24

28.07%

18.01%

842.04%

33.82%

QoQ growth

QuarterlyAnnual

Sentiment analysis

-1.5

Neutral

+1.5

0.08

Last 30 days

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Medpace Holdings Inc share?

Medpace Holdings Inc shares are currently traded for $341.14 per share.

How many shares does Medpace Holdings Inc have?

Medpace Holdings Inc currently has 31.1M shares.

Does Medpace Holdings Inc pay dividends?

No, Medpace Holdings Inc doesn't pay dividends.

What is Medpace Holdings Inc 52 week high?

Medpace Holdings Inc 52 week high is $459.77.

What is Medpace Holdings Inc 52 week low?

Medpace Holdings Inc 52 week low is $277.72.

What is the 200-day moving average of Medpace Holdings Inc?

Medpace Holdings Inc 200-day moving average is $374.55.

Who is Medpace Holdings Inc CEO?

The CEO of Medpace Holdings Inc is Dr. August James Troendle M.D..

How many employees Medpace Holdings Inc has?

Medpace Holdings Inc has 5,900 employees.

What is the market cap of Medpace Holdings Inc?

The market cap of Medpace Holdings Inc is $10.7B.

What is the P/E of Medpace Holdings Inc?

The current P/E of Medpace Holdings Inc is 30.03.

What is the EPS of Medpace Holdings Inc?

The EPS of Medpace Holdings Inc is $11.41.

What is the PEG Ratio of Medpace Holdings Inc?

The PEG Ration of Medpace Holdings Inc is 1.63.

What do analysts say about Medpace Holdings Inc?

According to the analysts Medpace Holdings Inc is considered a hold.

Medpace Holdings Inc news

thumbs_up_down

•Neutral

The Schall Law Firm Invites Shareholder Contributions To An Inquiry Into Medpace Holdings Inc For Securities Law Violations

LOS ANGELES, CA / ACCESSWIRE / December 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Accesswire•24 Dec 2024, 17:15

thumb_up_alt

•Positive

Is Medpace (MEDP) Stock Outpacing Its Medical Peers This Year?

Here is how Medpace (MEDP) and Clover Health Investments, Corp. (CLOV) have performed compared to their sector so far this year.

Zacks Investment Research•24 Dec 2024, 15:41

thumb_down_alt

•Negative

Medpace (MEDP) Rises Yet Lags Behind Market: Some Facts Worth Knowing

Medpace (MEDP) closed the most recent trading day at $339.05, moving +0.52% from the previous trading session.

Zacks Investment Research•24 Dec 2024, 00:21